Cell therapy weekly: initiative to advance stem cell research and treatments makes California state ballot

Written by RegMedNet

This week: Green Cross LabCell (Yongin, South Korea) has announced its procurement of a patent from the Japanese Patent Office for a natural killer (NK) cell culture method, Cynata Therapeutics (Melbourne, Australia) has announced its receipt of ethical approval from the University of Sydney Human Research Ethics Committee (Sydney, Australia) for a Phase III clinical trial of a mesenchymal stem cell (MSC) product for osteoarthritis and Orca Bio (CA, USA) has announced US$192 million in Series D financing. The news highlights: Initiative to advance stem cell research and treatments makes California state ballot Japanese patent procured to allow continued commercialization...

To view the full article, please register now for access

It's completely free